23 Views

CRT 2026

Innovation and Technology

Session:: HBD West 2026 | Positioning US-Japan Synergies for the Future [Non-CME]

Panel Discussion | What Else is Needed to Demonstrate the Feasibility of Global Registries?

Sunday, March 8, 2026

10:35 AM - 11:20 AM EST

Location: Cabinet

Moderator(s)

David Erlinge, MD, PhD

Professor, Consultant Interventional Cardiology
Lund University
Lund, Sweden

Disclosure(s): chiesi, bracco: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); kaminari, medical: Consulting Fees (e.g., advisory boards) (Ongoing)
Misti Malone, PhD

Assistant Director, Office of Cardiovascular Devices
FDA
Silver Spring, Maryland, United States

Disclosure(s): No financial relationships to disclose

Panel Discussant(s)

SI

Shin Iwamoto, PhD

Deputy Review Director
Pharmaceuticals and medical devices agency
Chiyoda-ku, Tokyo, Japan

Disclosure(s): No financial relationships to disclose
Mitchell Krucoff, MD, FACC, FAHA, FSCAI

Professor Medicine/Cardiology
Duke University Medical Center/Duke Clinical Research Institute
Durham, North Carolina, United States

Disclosure(s): Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Abiomed / Johnson & Johnson: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Getinge: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Nipro Corporation: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Shockwave/Johnson&Johnson: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Terumo Corporation: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)
Mauro Moscucci, MD, MBA, MPH

Medical Officer
Food and Drug Administration, Center for Devices and Radiological Health, Maryland, United States

Disclosure(s): No financial relationships to disclose

Disclosure(s):

David Erlinge, MD, PhD: chiesi, bracco: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); kaminari, medical: Consulting Fees (e.g., advisory boards) (Ongoing)

Misti Malone, PhD: No financial relationships to disclose

Shin Iwamoto, PhD: No financial relationships to disclose

Mitchell Krucoff, MD, FACC, FAHA, FSCAI: Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Abiomed / Johnson & Johnson: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Getinge: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Nipro Corporation: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Shockwave/Johnson&Johnson: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Terumo Corporation: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)

Mauro Moscucci, MD, MBA, MPH: No financial relationships to disclose